Aβ43 is more frequent than Aβ40 in amyloid plaque cores from Alzheimer disease brains

Journal of Neurochemistry

Volumn 110, Issue 2, 2009, Pages 697-706

  Welander, Hedvig ^a   Frånberg, Jenny ^a   Graff, Caroline ^a   Sundström, Erik ^a   Winblad, Bengt ^a   Tjernberg, Lars O ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alzheimer disease; Amyloid peptide variants; Human brain; Immunohistochemistry; Mass spectrometry; Quantification

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN 43; AMYLOID BETA PROTEIN[1-40]; CYANOGEN BROMIDE; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN (1 43); AMYLOID BETA-PROTEIN (1-43); PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ARTICLE; ELECTROSPRAY MASS SPECTROMETRY; FRONTAL CORTEX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEUROTOXICITY; OCCIPITAL CORTEX; OLIGOMERIZATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENILE PLAQUE; ADULT; AGED; BIOSYNTHESIS; BRAIN LEVEL; CHEMISTRY; COMPARATIVE STUDY; FEMALE; GENETIC VARIABILITY; GENETICS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BRAIN CHEMISTRY; FEMALE; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; SENILE PLAQUES;

EID: 67649488309     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06170.x     Document Type: Article

References (46)

1. Arnold S. E., Hyman B. T., Flory J., Damasio A. R. Van Hoesen G. W. (1991) The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb. Cortex 1, 103 116.
2. Bitan G., Lomakin A. Teplow D. B. (2001) Amyloid β-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J. Biol. Chem. 276, 35176 35184.
3. Borchelt D. R., Thinakaran G., Eckman C. B. et al. (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate abeta1-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005 1013. (Pubitemid 26424026)
4. Citron M., Westaway D., Xia W. et al. (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nat. Med. 3, 67 72. (Pubitemid 27019143)
5. Crouch P. J., Harding S.-M. E., White A. R., Camakaris J., Bush A. I. Masters C. L. (2008) Mechanisms of Aβ mediated neurodegeneration in Alzheimer's disease. Int. J. Biochem. Cell Biol. 40, 181 198. (Pubitemid 350137874)
6. Dahlgren K. N., Manelli A. M., Stine W. B., Baker L. K., Krafft G. A. LaDu M. J. (2002) Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J. Biol. Chem. 277, 32046 32053. (Pubitemid 34969015)
7. Esh C., Patton L., Kalback W. et al. (2005) Altered APP processing in PDAPP (Val717 - Phe) transgenic mice yields extended-length Aβ peptides. Biochemistry 44, 13807 13819. (Pubitemid 41507461)
8. Glenner G. Wong C. W. (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885 890. (Pubitemid 14104991)
9. Goate A., Chartier-Harlin M.-C., Mullan M. et al. (1991) Segregation of the missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704 706. (Pubitemid 21912142)
10. Gowing E., Roher A. E., Woods A. S., Cotter R. J., Chaney M., Little S. P. Ball M. J. (1994) Chemical characterization of Aβ 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. J. Biol. Chem. 269, 10987 10990.
11. Gravina S. A., Ho L., Eckman C. B., Long K. E., Otvos L., Younkin L. H., Suzuki N. Younkin S. G. (1995) Amyloid β protein (Aβ) in Alzheimer's disease brains. J. Biol. Chem. 270, 7013 7016.
12. Gu Y., Misonou H., Sato T., Dohmae N., Takio K. Ihara Y. (2001) Distinct intramembrane cleavage of the β-amyloid precursor protein family resembling γ-secretase-like cleavage of Notch. J. Biol. Chem. 276, 35235 35238.
13. Gu Y., Sanjo N., Chen F. et al. (2004) The presenilin proteins are components of multiple membrane-bound complexes that have different biological activities. J. Biol. Chem. 279, 31329 31336. (Pubitemid 39037799)
14. Hardy J. A. Higgins G. A. (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184 185.
15. Hardy J. Selkoe D. J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353 356. (Pubitemid 34790756)
16. Iijima K., Liu H.-P., Chiang A.-S., Hearn S. A., Konsolaki M. Zhong Y. (2004) Dissecting the pathological effects of human Aβ40 and Aβ42 in Drosophila: a potential model for Alzheimer's disease. PNAS 101, 6623 6628. (Pubitemid 38586024)
17. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N. Ihara Y. (1994) Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 13, 45 53.
18. Jan A., Gokce O., Luthi-Carter R. Lashuel H. A. (2008) The ratio of monomeric to aggregated forms of Aβ40 and Aβ42 is an important determinant of amyloid-β aggregation, fibrillogenesis, and toxicity. J. Biol. Chem. 283, 28176 28189.
19. Jarrett J. T., Berger E. P. Landsbury P. T. Jr. (1993) The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693 4697. (Pubitemid 23162022)
20. Klein W. L. (2002) Aβ toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem. Int. 41, 345 352. (Pubitemid 34899424)
21. Levy-Lahad E., Wasco W., Poorkaj P. et al. (1995) Candidate gene for chromosome 1 familial Alzheimer's disease locus. Science 269, 973 977.
22. Masters C. L., Simms G., Weinmann N. A., Multhaup G., McDonald B. L. Beyreuther K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl Acad. Sci. USA 82, 4245 4249. (Pubitemid 15053619)
23. McGowan E., Pickford F., Kim J. et al. (2005) Aβ42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 47, 191 199. (Pubitemid 41019251)
24. Miravalle L., Calero M., Takao M., Roher A. E., Ghetti B. Vidal R. (2005) Amino-terminally truncated Aβ peptide species are the main component of cotton wool plaques. Biochemistry 44, 10810 10821. (Pubitemid 41153641)
25. Mirra S. S., Heyman A., Mckeel D. et al. (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479 486.
26. Näslund J., Haroutunian V., Mohs R., Davis K. L., Davies P., Greengard P. Buxbaum J. D. (2000) Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline. JAMA 283, 1571 1577. (Pubitemid 30161512)
27. Qi-Takahara Y., Morishima-Kawashima M., Tanimura Y. et al. (2005) Longer forms of amyloid β protein: implications for the mechanism of intramembrane cleavage by γ-secretase. J. Neurosci. 25, 436 445. (Pubitemid 40105614)
28. Rogaev E. I., Sherrington R., Rogaeva E. A. et al. (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376, 775 778.
29. 770 mutation V717F generates peptides longer than amyloid-β-(40-42) and flocculent amyloid aggregates. J. Biol. Chem. 7, 5829 5836. (Pubitemid 38220614)
30. Sastre M., Steiner H., Fuchs K., Capell A., Multhaup G., Condron M. M., Teplow D. B. Haass C. (2001) Presenilin-dependent γ-secretase processing of β-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Rep. 2, 835 841. (Pubitemid 32982753)
31. Scheuner D., Eckman C., Jensen M. et al. (1996) Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2, 864 870. (Pubitemid 26296755)
32. Selkoe D. J. (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81, 741 766. (Pubitemid 32267077)
33. Shankar G. M., Li S., Mehta T. H. et al. (2008) Amyloid-β protein dimers isolated directly from Alzheimer's disease brains impair synaptic plasticity and memory. Nat. Med. 14, 837 842.
34. Sherrington R., Rogaev E. I., Liang Y. et al. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754 760.
35. Shimojo M., Sahara N., Mizoroki T., Funamoto S., Morishima-Kawashima M., Kudo T., Takeda M., Ihara Y., Ichinose H. Takashima A. (2008) Enzymatic characteristics of I213T mutant presenilin-1/γ-secretase in cell models and knock-in mouse brains: FAD-linked mutation impairs γ-site cleavage of APP-CTFβ. J. Biol. Chem. 283, 16488 16496.
36. Söderberg L., Bogdanovic N., Axelsson B., Winblad B., Näslund J. Tjernberg L. O. (2006) Analysis of single Alzheimer solid plaque cores by laser capture microscopy and nanoelectrospray/tandem mass spectrometry. Biochemistry 45, 9849 9856. (Pubitemid 44257430)
37. Van Vickle G. D., Esh C. L., Kalback W. M. et al. (2007) TgCRND8 amyloid precursor protein transgenic mice exhibit an altered γ-secretase processing and an aggressive, additive amyloid pathology subject to immunotherapeutic modulation. Biochemistry 46, 10317 10327. (Pubitemid 350067625)
38. Van Vickle G. D., Esh C. L., Kokjohn T. A. et al. (2008) Presenilin-1 280Glu-Ala mutation alters c-terminal APP processing yielding longer Aβ peptides: implications for Alzheimer's disease. Mol. Med. 14, 184 194.
39. Vassar R., Bennett B. D., Babu-Khan S. et al. (1999) β-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735 741.
40. Walker L. C., Pahnke J., Madauss M. et al. (2000) Apolipoprotein E4 promotes the early deposition of Aβ42 and then Aβ40 in the elderly. Acta Neuropathol. 100, 36 42. (Pubitemid 30352866)
41. Ward R. V., Jennings K. H., Jepras R. et al. (2000) Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of β-amyloid peptide. Biochem. J. 348, 137 144. (Pubitemid 30312141)
42. Weidemann A., Eggert S., Reinhard F. M., Vogel M., Paliga K., Baier G., Masters C. L., Beyreuther K. Evin G. (2002) A novel η-cleavage within the transmembrane domain of the Alzheimer precursor protein demonstrates homology with Notch processing. Biochemistry 41, 2825 2835. (Pubitemid 34168952)
43. Wolfe M. S. (2007) When loss is gain: reduced presenilin proteolytic function leads to increased Aβ42/Aβ40. Talking point on the role of presenilin mutations in Alzheimer disease. EMBO Rep. 8, 136 140. (Pubitemid 46420840)
44. Yagishita S., Morishima-Kawashima M., Tanimura Y., Ishiura S. Ihara Y. (2006) DAPT-induced intracellular accumulations of longer amyloid β-proteins: further implications for the mechanism of intramembrane cleavage by γ-secretase. Biochemistry 45, 3952 3960.
45. Yu C., Kim S.-H., Ikeuchi T., Xu H., Gasparini L., Wang R. Sisodia S. S. (2001) Characterization of a presenilin-mediated amyloid precursor protein carboxyl-terminal fragment γ. Evidence for distinct mechanisms involved in γ-secretase processing of the APP and Notch1 transmembrane domains. J. Biol. Chem. 276, 43756 43760.
46. Zhao G., Mao G., Tan J., Dong Y., Cui M.-Z., Kim S.-H. Xu X. (2004) Identification of a new presenilin-dependent ζ-cleavage site within the transmembrane domain of amyloid precursor protein. J. Biol. Chem. 279, 50647 50650. (Pubitemid 40017799)